Wise Adina H, Yang Amy, Naik Hetanshi, Stauffer Chanan, Zeid Natasha, Liong Christopher, Balwani Manisha, Desnick Robert J, Alcalay Roy N
Department of Neurology, Columbia University Medical Center, 710 W. 168th St., New York, NY 10032, United States.
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai Hospital, 1428 Madison Ave, Atran Building, 1st Floor, New York, NY 10029, United States.
Mol Genet Metab Rep. 2017 Nov 9;14:27-30. doi: 10.1016/j.ymgmr.2017.10.013. eCollection 2018 Mar.
Recent research has suggested a possible link between Parkinson's disease (PD) and Fabry disease. To test this relationship, we administered a self-report and family history questionnaire to determine the prevalence of PD in Fabry disease patients and family members with likely pathogenic alpha-galactosidase A (GLA) mutations. A total of 90 Fabry patients (77 from the online survey and 13 from the Icahn School of Medicine at Mount Sinai (ISMMS)) were included in the analysis. Two of the Fabry disease patients who completed the online survey were diagnosed with PD (2/90, 2.2%). Among probands older than 60, 8.3% (2/24) were diagnosed with PD. Using Kaplan Meier survival analysis, the age-specific risk of PD by age 70 was 11.1%. Family history was available on 72 Fabry families from the online study and 9 Fabry families from ISMMS. Among these 81 families, 6 (7.4%) had one first degree relative who fit the criteria for a conservative diagnosis of PD. The results of this study suggest that there may be an increased risk of developing PD in individuals with GLA mutations, but these findings should be interpreted with caution given the limitations of the study design.
最近的研究表明帕金森病(PD)与法布里病之间可能存在联系。为了验证这种关系,我们发放了一份自我报告和家族病史调查问卷,以确定法布里病患者及携带可能致病的α-半乳糖苷酶A(GLA)突变的家庭成员中帕金森病的患病率。共有90名法布里病患者(77名来自在线调查,13名来自西奈山伊坎医学院(ISMMS))纳入分析。完成在线调查的法布里病患者中有2人被诊断为帕金森病(2/90,2.2%)。在60岁以上的先证者中,8.3%(2/24)被诊断为帕金森病。使用Kaplan Meier生存分析,70岁时帕金森病的年龄特异性风险为11.1%。在线研究中的72个法布里病家族和ISMMS的9个法布里病家族提供了家族病史。在这81个家族中,6个(7.4%)有一位符合帕金森病保守诊断标准的一级亲属。本研究结果表明,携带GLA突变的个体患帕金森病的风险可能增加,但鉴于研究设计的局限性,这些发现应谨慎解读。